Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States

被引:108
作者
Ahuja, TS
Grady, J
Khan, S
机构
[1] Univ Texas, Med Branch, Dept Med, Div Nephrol, Galveston, TX 77550 USA
[2] Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Div Epidemiol & Biostat, Galveston, TX 77550 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷 / 07期
关键词
D O I
10.1097/01.ASN.0000019773.43765.BF
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
HIV-infected patients with end-stage renal disease have a very high morbidity and mortality. In the last decade, survival of HIV-infected patients in the United States has remarkably improved. To determine whether similar improvement in survival has occurred in HIV-infected dialysis patients, their survival was evaluated by using the United States Renal Data System database. Survival of HIV-infected dialysis patients in the United States was determined and the influence of year of initiation of dialysis, and demographic characteristics on the survival were analyzed by the Kaplan-Meier method. The effects of above variables on survival were also examined in a Cox proportional hazards model. Identified were 6166 HIV-infected patients with end-stage renal disease who received dialysis in the United States. Eighty-nine percent of the patients were black, 7.4% white, and 3% other. From 1990 to 1999, 1-yr survival of HIV-infected patients on dialysis improved from 56 to 74%, and the annual death rates declined from 458 deaths to 240 deaths per 1000 patient-years. The hazard ratio declined significantly in patients who initiated dialysis in years 1999-2000 compared with patients who initiated dialysis less than or equal to 1990 (hazard ratio, 0.49; 95% confidence interval, 0.40 to 0.60). Survival of HIV-infected dialysis patients has remarkably improved in the United States.
引用
收藏
页码:1889 / 1893
页数:5
相关论文
共 29 条
  • [1] Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients
    Ahuja, TS
    Borucki, M
    Grady, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) : 574 - 580
  • [2] Is the prevalence of HIV-associated nephropathy decreasing?
    Ahuja, TS
    Borucki, M
    Funtanilla, M
    Shahinian, V
    Hollander, M
    Rajaraman, S
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1999, 19 (06) : 655 - 659
  • [3] PLASMA INTERLEUKIN-1 ACTIVITY DURING HEMODIALYSIS - THE INFLUENCE OF DIALYSIS MEMBRANES
    BINGEL, M
    LONNEMANN, G
    KOCH, KM
    DINARELLO, CA
    SHALDON, S
    [J]. NEPHRON, 1988, 50 (04): : 273 - 276
  • [4] BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231
  • [5] *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P861
  • [6] PATHOLOGY OF HIV-ASSOCIATED NEPHROPATHY - A DETAILED MORPHOLOGIC AND COMPARATIVE-STUDY
    DAGATI, V
    SUH, JI
    CARBONE, L
    CHENG, JT
    APPEL, G
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (06) : 1358 - 1370
  • [7] Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
    Detels, R
    Muñoz, A
    McFarlane, G
    Kingsley, LA
    Margolick, JB
    Giorgi, J
    Scharager, LD
    Phair, JP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (17): : 1497 - 1503
  • [8] FEINFELD DA, 1989, CLIN NEPHROL, V32, P221
  • [9] INFLUENCE OF UREMIA AND HEMODIALYSIS ON CIRCULATING INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA
    HERBELIN, A
    NGUYEN, AT
    ZINGRAFF, J
    URENA, P
    DESCAMPSLATSCHA, B
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (01) : 116 - 125
  • [10] Ifudu O, 1997, AM J KIDNEY DIS, V29, P549, DOI 10.1016/S0272-6386(97)90336-X